• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME BIOSURGERY (SEPRAMESH) SEPRAMESH IP; MCN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME BIOSURGERY (SEPRAMESH) SEPRAMESH IP; MCN Back to Search Results
Lot Number 06NP104
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Emotional Changes (1831); Pain (1994); Anxiety (2328); Distress (2329); Injury (2348)
Event Type  Injury  
Event Description
Severe personal injury/permanent injuries [permanent injury].Bowel densely adherent to the mesh [bowel adhesions].Mental anguish [anguish].Severe emotional distress [emotional distress].Significant physical pain [pain].Case narrative: initial information received on 31-may-2019 from united states regarding an unsolicited legal valid serious case received from a lawyer.This case involves patient with unknown demographics who experienced bowel densely adherent to the mesh, severe personal injury/permanent injuries, mental anguish, severe emotional distress and significant physical pain, after having implant of the medical device carboxymethylcellulose, polyglycolic acid, polypropylene, sodium hyaluronate (sepramesh ip).The patient's past medical history included repair of ventral hernia on (b)(6) 2005 (lot number: 43kod268) with composix kugel was used in the surgery for the repair of ventral hernia.Patient's past medical treatment(s), vaccination(s) and family history were not provided.On (b)(6) 2007, the patient underwent surgery for repair of recurrent complex ventral hernia and carboxymethylcellulose, polyglycolic acid, polypropylene, sodium hyaluronate was implanted (batch number-06np104) to repair the hernia defect.On (b)(6) 2015, patient underwent an additional surgery to excise the meshoma.It was observed that a very thick dinner plate type scar tissue containing the previously placed mesh, which surgeon incised and divided.In this course mesh was found and was noticed that bowel was densely adherent to the mesh which was taken down using sharp dissection enterotomy in small bowel.Surgeon also created anastomosis as well.After all the adhesions were taken down, the surgeon repaired the recurrent hernia and performed a reconstruction using ventralight st mesh.The event of bowel densely adherent to the mesh was assessed as serious due to criteria of medically significant.On the unknown date, patient experienced serious severe personal injury.This event was assessed as medically significant and was leading to surgical intervention.Patient experienced permanent injuries, severe mental anguish, severe emotional distress, significant physical pain and suffering.Patient lost wages, earning capacity and diminished quality of life.Final diagnosis was bowel densely adherent to the mesh, severe personal injury/permanent injuries, mental anguish, severe emotional distress and significant physical pain.Action taken: not applicable for bowel densely adherent to the mesh, severe personal injury/permanent injuries, mental anguish, severe emotional distress and significant physical pain.Corrective treatment: surgery for bowel densely adherent to the mesh and severe personal injury/permanent injuries; not reported for rest of the events.Outcome: unknown for bowel densely adherent to the mesh, severe personal injury/permanent injuries, mental anguish, severe emotional distress and significant physical pain.A product technical compliant was initiated and results were pending for same.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SEPRAMESH IP
Type of Device
MCN
Manufacturer (Section D)
GENZYME BIOSURGERY (SEPRAMESH)
76 new york avenue
framingham 01701
Manufacturer (Section G)
GENZYME BIOSURGERY (SEPRAMESH)
76 new york avenue
framingham 01701
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
a
bridgewater 08807
MDR Report Key8700292
MDR Text Key148066475
Report Number1221601-2019-00012
Device Sequence Number1
Product Code MCN
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial
Report Date 06/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number06NP104
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/14/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-